GSE126463 0 V 3 POMALIDOMIDE HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE126463 0 V 3 POMALIDOMIDE HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE126463 0 V 3 POMALIDOMIDE HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE126463 0 V 3 POMALIDOMIDE HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE126463 0 V 3 POMALIDOMIDE HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

mitochondrial ribosomal protein S18B

Gene

cytochrome c oxidase assembly factor 4 homolog

Gene

DNA polymerase delta 3, accessory subunit

Gene

heterogeneous nuclear ribonucleoprotein L like

Gene

transmembrane protein 98

Gene

signal peptidase complex subunit 1

Gene

glutaredoxin 2

Gene

tRNA splicing endonuclease subunit 15

Gene

holocarboxylase synthetase

Gene

CCR4-NOT transcription complex subunit 9

  • Gene

    mitochondrial ribosomal protein S18B


  • Gene

    cytochrome c oxidase assembly factor 4 homolog


  • Gene

    DNA polymerase delta 3, accessory subunit


  • Gene

    heterogeneous nuclear ribonucleoprotein L like


  • Gene

    transmembrane protein 98


  • Gene

    signal peptidase complex subunit 1



  • Gene

    tRNA splicing endonuclease subunit 15


  • Gene

    holocarboxylase synthetase


  • Gene

    CCR4-NOT transcription complex subunit 9

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.